Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Phreesia stock

Learn how to easily invest in Phreesia stock.

Phreesia Inc is a health information services business based in the US. Phreesia shares (PHR) are listed on the NYSE and all prices are listed in US Dollars. Phreesia employs 827 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Phreesia

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PHR – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Phreesia stock price (NYSE: PHR)

Use our graph to track the performance of PHR stocks over time.

Phreesia shares at a glance

Information last updated 2022-01-23.
Latest market close$28.93
52-week range$28.34 - $81.59
50-day moving average $48.94
200-day moving average $57.91
Wall St. target price$59.23
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.64

Buy Phreesia shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Phreesia stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Phreesia price performance over time

Historical closes compared with the close of $28.93 from 2022-01-26

1 week (2022-01-20) -6.68%
1 month (2021-12-27) -35.37%
3 months (2021-10-27) -56.46%
6 months (2021-07-27) -56.92%
1 year (2021-01-27) -54.58%
2 years (2020-01-27) -1.13%
3 years (2019-01-23) N/A
5 years (2017-01-23) N/A

Phreesia financials

Revenue TTM $197 million
Gross profit TTM $96.3 million
Return on assets TTM -11.26%
Return on equity TTM -21.94%
Profit margin -40.51%
Book value $8.96
Market capitalisation $1.6 billion

TTM: trailing 12 months

Phreesia share dividends

We're not expecting Phreesia to pay a dividend over the next 12 months.

Phreesia share price volatility

Over the last 12 months, Phreesia's shares have ranged in value from as little as $28.34 up to $81.592. A popular way to gauge a stock's volatility is its "beta".

PHR.US volatility(beta: 1.27)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Phreesia's is 1.2711. This would suggest that Phreesia's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Phreesia overview

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; appointments solution for online appointments, reminders, and referral tracking; and patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and PRO data for approximately 25 specialties; and life sciences solution to deliver targeted and clinically relevant marketing content to patients, as well as COVID-19 product offerings for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies.

Frequently asked questions

What percentage of Phreesia is owned by insiders or institutions?
Currently 3.678% of Phreesia shares are held by insiders and 101.207% by institutions.
How many people work for Phreesia?
Latest data suggests 827 work at Phreesia.
When does the fiscal year end for Phreesia?
Phreesia's fiscal year ends in January.
Where is Phreesia based?
Phreesia's address is: 434 Fayetteville St, Raleigh, NC, United States, 27601
What is Phreesia's ISIN number?
Phreesia's international securities identification number is: US71944F1066
What is Phreesia's CUSIP number?
Phreesia's Committee on Uniform Securities Identification Procedures number is: 71944F106

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site